Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ablynx grabs cheap €100m top-up from bond investors before window shuts

This article was originally published in Scrip

Executive Summary

In the first significant return to the European bond market since Norwegian radiopharmaceutical specialist Algeta raised $120m back in September 2013, Belgian nanobody firm, Ablynx, has raised €100m ($110m) through a private placement of Senior Unsecured Convertible Bonds. According to CEO Edwin Moses, this provides Ablynx with "a lot more choice of how we spend our money, and options in product development." The bond route allowed Ablynx to raise its money rapidly and relatively cheaply.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts